Loading data for BIB — first visit, this takes a few seconds.
ProShares Ultra Nasdaq Bi... (BIB)
NasdaqGM: BIB
· Prix en temps réel · USD
116.62
-5.64 (-4.61%)
À la clôture : Aug 28, 2026, 4:54 PM
ProShares Ultra Nasdaq Biotechnology (BIB) : cours, positions et analyse de l'ETF
-4.61% (1D)
Aucune donnée disponible
| Bid | 98.19 |
| Capitalisation boursière | n/a |
| AUM | 78.22M |
| NAV | 123.82 |
| Bêta | 1.13 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 33.03 |
| Parts en circulation | n / A |
| Date de création | Apr 6, 2010 |
| Ask | 105.06 |
| Volume | 16,873 |
| Moy. Volume (20D) | 11,598 |
| Ouverture | 123.00 |
| Clôture précédente | 122.26 |
| Fourchette du jour | 118.50 - 123.15 |
| Intervalle de 52 semaines | 54.85 - 126.40 |
| Positions | n / A |
| Ratio de frais | 0.95% |
À propos de BIB
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Classe d’actifs Equity
Symbole boursier BIB
Date de création Apr 6, 2010
Fournisseur Proshares
Site web Page d’accueil du fonds
Échange NasdaqGM
Dividendes Rendement du dividende 0.42%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Mar 25, 2026 | $0.0070 | n / A |
| Dec 24, 2025 | $0.1350 | n / A |
| Sep 24, 2025 | $0.1810 | n / A |
| Jun 25, 2025 | $0.1710 | n / A |
| Mar 26, 2025 | $0.1310 | n / A |
